Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects

被引:25
作者
Tilly-Kiesi, M
Lichtenstein, AH
Joven, J
Vilella, E
Cheung, MC
Carrasco, WV
Ordovas, JM
Dolnikowski, G
Schaefer, EJ
机构
[1] Tufts Univ, Lipid Metab Lab, USDA, Jean Mayer Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[2] Tufts Univ, Mass Spectrometry Lab, USDA, Jean Mayer Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[3] Univ Helsinki, Cent Hosp, Helsinki, Finland
[4] Univ Hosp St Joan, Reus, Spain
[5] NW Lipid Res Labs, Seattle, WA USA
关键词
kinetics; LpAI; LpAI : AII; sex; lipoproteins;
D O I
10.1161/01.ATV.17.12.3513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The behavior of apolipoprotein (apo) A-I in lipoprotein (Lp) AI and LpAI:AII was studied in 11 postmenopausal females and 11 males matched for plasma triglyceride and total cholesterol levels. Subjects consumed a baseline diet [35% fat (14% saturated, 15% monounsaturated, and 7% polyunsaturated), 15% protein, 49% carbohydrate, and 147 mg cholesterol/1000 kcal] for 6 weeks before the start of the kinetic study. At the end of the diet period, using a primed-constant infusion of [5,5,5-H-2(3)]leucine. residence times (RT) and secretion rates (SR) of apoA-I were determined in 2 subpopulations of high-density lipoprotein (HDL) particles, LpAI and LpAI:AII. Plasma total cholesterol, low-density lipoprotein cholesterol, and triglyceride concentrations were similar in males and females. The mean plasma HDL cholesterol concentration in males (1.14+/-0.23 mmol/L mean+/-SD) was lower than in females (1.42+/-0.18 mmol/L; P=.0034). Similarly, the mean plasma concentration of apoA-I in males (130+/-21 mg/dL) was lower than that in females (150+/-19 mg/dL; P=.0421). The RT of apoA-I in either LpAI or LpAI:AII was similar between men and women. Despite the higher plasma apo A-I levels in female compared with male subjects, total apoA-I and apoA-I in LpAI and LpAI:AII pool sizes were similar weight of the female subjects. The mean SR of total apoA-I in males (8.5+/-2.7 mg . kg(-1) . d(-1)) was 22% lower than in females (10.9+/-2.3 mg . kg(-1) . d(-1); P=.0389). The SR of both apoA-I in LpAI and LpAI:AII was lower in males than females, although the differences did not reach statistical significance. These data suggest that the difference observed in HDL cholesterol concentration between males and females in attributable to SR of apoA-I and not the catabolic rate.
引用
收藏
页码:3513 / 3518
页数:6
相关论文
共 41 条
[1]   SUBPOPULATIONS OF APOLIPOPROTEIN-A-I IN HUMAN HIGH-DENSITY LIPOPROTEINS THEIR METABOLIC PROPERTIES AND RESPONSE TO DRUG-THERAPY [J].
ATMEH, RF ;
SHEPHERD, J ;
PACKARD, CJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 751 (02) :175-188
[2]   ELEVATED HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS CORRELATE WITH DECREASED APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-A-II FRACTIONAL CATABOLIC RATE IN WOMEN [J].
BRINTON, EA ;
EISENBERG, S ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (01) :262-269
[3]   INCREASED APO-A-I AND APO-A-II FRACTIONAL CATABOLIC RATE IN PATIENTS WITH LOW HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL LEVELS WITH OR WITHOUT HYPERTRIGLYCERIDEMIA [J].
BRINTON, EA ;
EISENBERG, S ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :536-544
[4]   HUMAN HDL CHOLESTEROL LEVELS ARE DETERMINED BY APOA-I FRACTIONAL CATABOLIC RATE, WHICH CORRELATES INVERSELY WITH ESTIMATES OF HDL PARTICLE-SIZE [J].
BRINTON, EA ;
EISENBERG, S ;
BRESLOW, JL .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (05) :707-720
[5]  
CHEUNG MC, 1982, J LIPID RES, V23, P747
[6]  
CHEUNG MC, 1984, J BIOL CHEM, V259, P2201
[7]  
COHN JS, 1988, J LIPID RES, V29, P925
[8]  
COSTEBUREL M, 1990, CLIN CHEM, V36, P1889
[9]   DISTRIBUTION OF SUBCLASSES OF HDL CONTAINING APOA-I WITHOUT APOA-II (LPA-I) IN NORMOLIPIDEMIC MEN AND WOMEN [J].
DUVERGER, N ;
RADER, D ;
BREWER, HB .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (10) :1594-1599
[10]   TURNOVER OF APOPROTEINS A-I AND A-II OF HIGH-DENSITY LIPOPROTEIN AND THE RELATIONSHIP TO OTHER LIPOPROTEINS IN NORMAL AND HYPERLIPIDEMIC INDIVIDUALS [J].
FIDGE, N ;
NESTEL, P ;
ISHIKAWA, T ;
REARDON, M ;
BILLINGTON, T .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1980, 29 (07) :643-653